Safety and Effectiveness of Bevacizumab Treatment for Metastatic Colorectal Cancer: Final Results from the Avastin® Registry – Investigation of Effectiveness and Safety (ARIES) Observational Cohort Study
Hurwitz, H.I, Bekaii-Saab, T.S, Bendell, J.C, Cohn, A.L, Kozloff, M, Roach, N, Mun, Y, Fish, S, Flick, E.D, Grothey, A
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.06.2014)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.06.2014)
Get full text
Journal Article
6013 POSTER DISCUSSION Cumulative Exposure to Bevacizumab (BV) After Progression Correlates With Increased Survival in Patients (pts) With Metastatic Colorectal Cancer (mCRC): a Time-dependent Analysis of the ARIES Observational Cohort Study
Grothev, A, Bekaii-Saab, T.S, Hurwitz, H, Kozloff, M, Roach, N, Mun, Y, Fish, S, Flick, E.D, Dalai, D, Conn, A.L
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
458P Phase (Ph) I/Ib trial of fruquintinib (fru) in patients (pts) with advanced solid tumors: Preliminary results of the dose expansion (exp) cohort in refractory metastatic colorectal cancer (mCRC)
Dasari, N.A., Wang-Gillam, A., Hubbard, J.M., Fernandez, A., Nanda, S., Kania, M., Schelman, W.R., Bekaii-Saab, T.S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
P1.15-08 Phase 1: IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy as Monotherapy or in Combination with Atezolizumab, in Adults with Non-Small Cell Lung Cancer
Richardson, G.E., Park, J.J., Boyer, M.J., Gutierrez, M., Carbone, D.P., Savvides, P., Kaumaya, P., Bekaii-Saab, T.S., Phan, T.G., Chong, L.M.O., Cha, S., Ede, N., Nixon, B., Withana, N.P., Good, A.J.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA
Martin, L.K., Li, X., Kleiber, B., Ellison, E.C., Bloomston, M., Zalupski, M., Bekaii-Saab, T.S.
Published in Annals of oncology (01.11.2012)
Published in Annals of oncology (01.11.2012)
Get full text
Journal Article